IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$1.67
Tradestie Score
52
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+251.8%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$8.74
|
$281.75M | 8.9 | 48 | Compare |
|
DBVT
DBV Technologies S.A.
|
$17.42
|
$275.54M | - | 57 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.90
|
$275.13M | - | 48 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.36
|
$269.08M | - | 55 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.83
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.32
|
$202.58M | - | 54 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$17.92
|
$199.71M | - | 48 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.76
|
$170.45M | - | 48 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.52
|
$158.43M | - | 59 | Compare |
More IKT Analysis
Data updated: Jun 14, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry